methylprednisolone has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Hirano, T; Wang, X; Wu, H; Xu, W; Yamada, H | 1 |
Guglin, M; Haq, M; Patel, A | 1 |
Beesley, AH; Heng, JY; Kees, UR; Samuels, AL | 1 |
Beesley, AH; Firth, MJ; Ford, J; Freitas, JR; Kees, UR; Perera, KU; Weller, RE | 1 |
Brdicka, T; Kalina, T; Kanderova, V; Skopcova, T; Svojgr, K; Zuna, J | 1 |
Asano, T; Fujino, O; Kaizu, K; Koizumi, S; Miyatake, C; Narazaki, H | 1 |
6 other study(ies) available for methylprednisolone and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Methylprednisolone potentiates tetrandrine pharmacodynamics against human T lymphoblastoid leukemia MOLT-4 cells via regulation of NF-κB activation and cell cycle transition.
Topics: Antineoplastic Agents; Benzylisoquinolines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Drug Synergism; Humans; Methylprednisolone; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Signal Transduction | 2020 |
Cardiac lymphoma: sinus pauses disappear after chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Cisplatin; Cytarabine; Etoposide; Female; Humans; Methylprednisolone; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sick Sinus Syndrome | 2014 |
Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Galactose; Glucocorticoids; Glycolysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methylprednisolone; Mitochondria; Oligomycins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction | 2014 |
Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
Topics: Cell Proliferation; Dexamethasone; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Glucocorticoids; Humans; Methylprednisolone; Oligonucleotide Array Sequence Analysis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Tumor Cells, Cultured | 2009 |
The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL.
Topics: Adaptor Proteins, Signal Transducing; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; Butadienes; Drug Resistance, Neoplasm; Humans; In Vitro Techniques; Jurkat Cells; Lectins, C-Type; MAP Kinase Signaling System; Methylprednisolone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Proteins; Nitriles; Phosphorylation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Receptors, Antigen, T-Cell | 2012 |
Delayed-type hypersensitivity in response to L-asparaginase in a case of acute lymphoblastic leukemia.
Topics: Administration, Intravenous; Anti-Inflammatory Agents; Antineoplastic Agents; Asparaginase; Child, Preschool; Dexamethasone; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Hypersensitivity, Delayed; Methylprednisolone; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2012 |